EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An RNAi-Mediated Reduction in Transcription Factor Nrf-2 Blocks the Positive Effects of Dimethyl Fumarate on Metabolic Stress in Alzheimer’s Disease

Marika Lanza, Rossella Basilotta, Salvatore Cuzzocrea iD, Maria Bulzomì, Salvatore Oddo iD, Giovanna Casili, Emanuela Esposito iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241411303 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Marika Lanza und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale F. Stagno d'Alcontres 31, 98166 Messina, …. Hauptthemen laut MEDLINE: Alzheimer Disease, Dimethyl Fumarate, Neuroprotective Agents, RNA Interference. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The prevalence of obesity is rapidly rising around the world, and this will have a significant impact on our society as it is believed to be one of the leading causes of death. One of the main causes of these occurrences is added sugar consumption, which is associated with a higher risk of obesity, heart disease, diabetes, and brain illnesses such as Alzheimer’s disease (AD). To this purpose, excess sugar might worsen oxidative damage and brain inflammation: two neuropathological signs of AD. Dimethyl fumarate (DMF) is an orally accessible methyl ester of fumaric acid with putative neuroprotective and immunomodulatory properties. In addition, DMF stimulates the nuclear factor erythroid 2-related factor 2 (Nrf-2), a key regulator of the antioxidant response mechanism in cells. The aim of the current study was to assess the potential therapeutic benefits of DMF in an in vitro model of metabolic stress induced by high and low sugar levels. We discovered that DMF reversed the negative impacts of high and low glucose exposure on the viability and oxidative stress of SH-SY5Y cells. Mechanistically, DMF’s actions were mediated by Nrf-2. To this end, we discovered that DMF boosted the expression of the Nrf-2-regulated genes heme-oxygenase-1 (HO1) and manganese superoxide dismutase (MnSOD). More importantly, we found that inhibiting Nrf-2 expression prevented DMF’s positive effects. Our combined findings suggest that DMF may be a valuable support for treatments for metabolic diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseDimethyl FumarateNeuroprotective AgentsRNA InterferenceHumansNF-E2-Related Factor 2Oxidative StressCell Line, Tumor

Stichwörter der Autor:innen

Alzheimer’s diseasebrainmetabolic stressneurodegenerationneuroinflammationoxidative stress

Substanzen

Dimethyl FumarateNeuroprotective AgentsNF-E2-Related Factor 2

Autor:innen und Institutionen

  • Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale F. Stagno d'Alcontres 31, 98166 Messina, Italy.

ORCID-Profile: Salvatore Cuzzocrea, Salvatore Oddo, Emanuela Esposito

Zitieren

APA

Lanza, M., Basilotta, R., Cuzzocrea, S., Bulzomì, M., Oddo, S., Casili, G., & Esposito, E. (2023). An RNAi-Mediated Reduction in Transcription Factor Nrf-2 Blocks the Positive Effects of Dimethyl Fumarate on Metabolic Stress in Alzheimer’s Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241411303

Vancouver

Lanza M, Basilotta R, Cuzzocrea S, Bulzomì M, Oddo S, Casili G, et al. An RNAi-Mediated Reduction in Transcription Factor Nrf-2 Blocks the Positive Effects of Dimethyl Fumarate on Metabolic Stress in Alzheimer’s Disease. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241411303

BibTeX
@article{Lanza2023,
  author = {Lanza, Marika and Basilotta, Rossella and Cuzzocrea, Salvatore and Bulzomì, Maria and Oddo, Salvatore and Casili, Giovanna and Esposito, Emanuela},
  title = {An RNAi-Mediated Reduction in Transcription Factor Nrf-2 Blocks the Positive Effects of Dimethyl Fumarate on Metabolic Stress in Alzheimer’s Disease},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241411303}
}
Kostenlos starten →